Sesamolin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt's lymphoma cells

International Immunopharmacology

Volumn 28, Issue 2, 2015, Pages 977-984

  Kim, Jeong Hwa ^a   Lee, Jae Kwon ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Natural killer cell; NKG2D ligands; Raji; Sesamin; Sesamolin

Indexed keywords

ANTINEOPLASTIC AGENT; LIGAND; LIGNAN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN KINASE B; SESAMIN; SESAMOLIN; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; LIGNAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BURKITT LYMPHOMA; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; DRUG CYTOTOXICITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL LINE; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; COMPARATIVE STUDY; CYTOTOXICITY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PLANT SEED; SESAMUM; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DIOXOLES; HUMANS; KILLER CELLS, NATURAL; LIGNANS; MAP KINASE SIGNALING SYSTEM; MOLECULAR TARGETED THERAPY; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SEEDS; SESAMUM; UP-REGULATION;

EID: 84940676412     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.08.014     Document Type: Article

References (41)

1. [1] McKevith, B., Nutritional aspects of oilseeds. Nutr. Bull. 30 (2005), 13–26.
2. [2] Jeng, K.C.G., Hou, R.C.W., Sesamin and sesamolin: nature's therapeutic lignans. Curr. Enzym. Inhib. 1 (2005), 11–20.
3. [3] Lim, J.S., Adachi, Y., Takahashi, Y., Ide, T., Comparative analysis of sesame lignans (sesamin and sesamolin) in affecting hepatic fatty acid metabolism in rats. Br. J. Nutr. 97 (2007), 85–95.
4. [4] Kamal-Eldin, A., Moazzami, A., Washi, S., Sesame seed lignans: potent physiological modulators and possible ingredients in functional foods & nutraceuticals. Recent Patents Food Nutr. Agric. 3 (2011), 17–29.
5. [5] Ide, T., Lim, J.S., Odbayar, T.O., Nakashima, Y., Comparative study of sesame lignans (sesamin, episesamin and sesamolin) affecting gene expression profile and fatty acid oxidation in rat liver. J. Nutr. Sci. Vitaminol. 55 (2009), 31–43.
6. [6] Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S., Functions of natural killer cells. Nat. Immunol. 9 (2008), 503–510.
7. [7] Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M.C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19 (2001), 197–223.
8. [8] Houchins, J.P., Yabe, T., McSherry, C., Bach, F.H., DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173 (1991), 1017–1020.
9. [9] Karpova, M.B., Schoumans, J., Ernberg, I., Henter, J.I., Nordenskjold, M., Fadeel, B., Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line. Leukemia 19 (2005), 159–161.
10. [10] Pulvertaft, J.V., Cytology of Burkitt's tumour (African lymphoma). Lancet 1 (1964), 238–240.
11. [11] Epstein, M.A., Achong, B.G., Barr, Y.M., Zajac, B., Henle, G., Henle, W., Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37 (1966), 547–559.
12. [12] Theofilopoulos, A.N., Wilson, C.B., Dixon, F.J., The Raji cell radioimmune assay for detecting immune complexes in human sera. J. Clin. Invest. 57 (1976), 169–182.
13. [13] Tam, Y.K., Maki, G., Miyagawa, B., Hennemann, B., Tonn, T., Klingemann, H.G., Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 10 (1999), 1359–1373.
14. [14] Shi, P., Yin, T., Zhou, F., Cui, P., Gou, S., Wang, C., Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway. BMC Cancer, 14, 2014, 370.
15. [15] Wu, X., Tao, Y., Hou, J., Meng, X., Shi, J., Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. Neoplasia 14 (2012), 1178–1189.
16. [16] Conejo-Garcia, J.R., Benencia, F., Courreges, M.C., Gimotty, P.A., Khang, E., Buckanovich, R.J., et al. Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28-antitumor T cells. Cancer Res. 64 (2004), 2175–2182.
17. [17] Guerra, N., Tan, Y.X., Joncker, N.T., Choy, A., Gallardo, F., Xiong, N., et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28 (2008), 571–580.
18. [18] Friese, M.A., Wischhusen, J., Wick, W., Weiler, M., Eisele, G., Steinle, A., et al. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res. 64 (2004), 7596–7603.
19. [19] Bae, J.H., Kim, J.Y., Kim, M.J., Chang, S.H., Park, Y.S., Son, C.H., et al. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J. Immunother. 33 (2010), 391–401.
20. [20] Bae, D.S., Hwang, Y.K., Lee, J.K., Importance of NKG2D–NKG2D ligands interaction for cytolytic activity of natural killer cell. Cell. Immunol. 276 (2012), 122–127.
21. [21] Nedvetzki, S., Sowinski, S., Eagle, R.A., Harris, J., Vely, F., Pende, D., et al. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109 (2007), 3776–3785.
22. [22] Rabinovich, B.A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D., et al. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170 (2003), 3572–3576.
23. [23] Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., Santoni, A., Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 110 (2007), 606–615.
24. [24] Armeanu, S., Bitzer, M., Lauer, U.M., Venturelli, S., Pathil, A., Krusch, M., et al. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 65 (2005), 6321–6329.
25. [25] Kato, N., Tanaka, J., Sugita, J., Toubai, T., Miura, Y., Ibata, M., et al. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 21 (2007), 2103–2108.
26. [26] Diermayr, S., Himmelreich, H., Durovic, B., Mathys-Schneeberger, A., Siegler, U., Langenkamp, U., et al. NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities. Blood 111 (2008), 1428–1436.
27. [27] Poggi, A., Catellani, S., Garuti, A., Pierri, I., Gobbi, M., Zocchi, M.R., Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia 23 (2009), 641–648.
28. [28] Chavez-Blanco, A., De la Cruz-Hernandez, E., Dominguez, G.I., Rodriguez-Cortez, O., Alatorre, B., Perez-Cardenas, E., et al. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate. Int. J. Oncol. 39 (2011), 1491–1499.
29. [29] Schrama, D., Terheyden, P., Otto, K., Kammerer, U., Brocker, E.B., Luhder, F., et al. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells. Eur. J. Immunol. 36 (2006), 65–72.
30. [30] Ebihara, T., Masuda, H., Akazawa, T., Shingai, M., Kikuta, H., Ariga, T., et al. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int. Immunol. 19 (2007), 1145–1155.
31. [31] Zhang, C., Zhang, J., Niu, J., Zhou, Z., Tian, Z., Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Hum. Immunol. 69 (2008), 490–500.
32. [32] Budowski, P., Recent research on sesamin, sesamolin, and related compounds. J. Am. Oil Chem. Soc. 41 (1964), 280–285.
33. [33] Beroza, M., The structure of sesamolin and its stereochemical relationship to sesamin, asarinin and pinoresinol. J. Am. Chem. Soc. 77 (1955), 3332–3334.
34. [34] Haslam, E., Haworth, R.D., The constituents of natural phenolic resins. Part XXIII. The constitution of sesamolin. J. Chem. Soc., 1955, 827–833 (Resumed).
35. [35] Hou, R.C.-W., Chen, H.-L., Tzen, J.T.C., Jeng, K.-C.G., Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. NeuroReport 14 (2003), 1815–1819.
36. [36] Cheng, F.C., Jinn, T.R., Hou, R.C., Tzen, J.T., Neuroprotective effects of sesamin and sesamolin on gerbil brain in cerebral ischemia. Int. J. Biomed. Sci. 2 (2006), 284–288.
37. [37] Bortul, R., Tazzari, P.L., Billi, A.M., Tabellini, G., Mantovani, I., Cappellini, A., et al. Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. Br. J. Haematol. 129 (2005), 677–686.
38. [38] Grandage, V.L., Gale, R.E., Linch, D.C., Khwaja, A., PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia 19 (2005), 586–594.
39. [39] Yin, B., Morgan, K., Hasz, D.E., Mao, Z., Largaespada, D.A., Nfl gene inactivation in acute myeloid leukemia cells confers cytarabine resistance through MAPK and mTOR pathways. Leukemia 20 (2006), 151–154.
40. [40] Ogbomo, H., Michaelis, M., Klassert, D., Doerr, H.W., Cinatl, J. Jr., Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells. Neoplasia 10 (2008), 1402–1410.
41. [41] Borchers, M.T., Harris, N.L., Wesselkamper, S.C., Vitucci, M., Cosman, D., NKG2D ligands are expressed on stressed human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (2006), L222–L231.